Onesource Specialty Pharma Limited — Others, 23-06-2025: Change in Director(s)

OneSource Specialty Pharma Limited has announced a board meeting to appoint Mr. Colin Michael Bond as an Additional Non-Executive Independent Director for a five-year term, subject to shareholder approval. Colin is a seasoned global finance executive with over 15 years as CFO of publicly listed companies across Europe and the US. He brings expertise in corporate finance, M&A, audit and risk committees, business transformation, and ESG initiatives. His strong financial background includes an MBA from London Business School and chartered accountancy qualifications, supporting strategic governance and operational efficiency.